Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Cell Tumor, Malignant”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT00283556
What this trial is testing

High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma

Who this might be right for
Malignant Glioma
Kentuckiana Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT00748657
What this trial is testing

Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary

Who this might be right for
Malignant Ovarian Epithelial TumorOvarian Granulosa Cell TumorOvarian Gynandroblastoma+5 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT04438382
What this trial is testing

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSteroid-Refractory Pneumonitis
ECOG-ACRIN Cancer Research Group 1
Testing effectiveness (Phase 2)Looking for participantsNCT03563729
What this trial is testing

Melanoma Metastasized to the Brain and Steroids

Who this might be right for
Malignant Melanoma
Inge Marie Svane 80
Not applicableStudy completedNCT06328491
What this trial is testing

Erdafitinib in Metastatic Steroid-cell Ovarian Cancer

Who this might be right for
Ovarian CancerSteroid Cell Tumor, Malignant
University Health Network, Toronto 1
Testing effectiveness (Phase 2)WithdrawnNCT05660421
What this trial is testing

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Douglas Johnson